Stocks in News: Cambrex Corporation. (NYSE:CBM), Aemetis (NASDAQ:AMTX), Arena Pharmaceuticals (NASDAQ:ARNA), Baidu Inc (ADR) (NASDAQ:BIDU), Express Scripts Holding Company (NASDAQ:ESRX)

On Monday shares of Cambrex Corporation. (NYSE:CBM) closed at $40.70. Company’s sales growth for last 5 years was 9.80% and EPS growth for next 5 years is recorded as 15.00%. Zacks upgraded shares of Cambrex Corp. (NYSE:CBM) from a hold rating to a buy rating in a report. They currently have $42.00 target price on the stock.

Aemetis, Inc. (NASDAQ:AMTX) in last trading activity fell -5.23% to close at $4.53. Company weekly performance is -4.63% while its quarterly performance stands at -6.60%. Aemetis, Inc. (NASDAQ:AMTX) is -65.91% away from its 52 week high. Aemetis Inc (NASDAQ:AMTX) on 7 May, reported a first quarter (Q1) 2015 net loss of USD 8.6 million (EUR 7.7m), against a profit of USD 7.7 million in a year back. “Our US ethanol operating results reflect the current industry experience of reduced margins during the first quarter, but we are seeing improving margins during the second quarter”, said Eric McAfee, Aemetis chairman and CEO.

On Monday shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) closed at $4.39. Company’s sales growth for last 5 years was 28.90%. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) on May 11, 2015, declared financial results for the first quarter ended March 31, 2015. Highlights included: Revenues totaled $12.3 million, including $6.6 million in net product sales of BELVIQ, and a $3.0 million milestone for approval of BELVIQ in South Korea; Research and development expenses totaled $22.0 million; General and administrative expenses totaled $8.4 million;

Baidu Inc (ADR) (NASDAQ:BIDU) in last trading activity fell -0.86% to close at $191.32. Company weekly performance is 0.25% while its quarterly performance stands at -8.38%. Baidu Inc (ADR) (NASDAQ:BIDU) is -24.08% away from its 52 week high. Baidu Inc. (ADR) (NASDAQ:BIDU) has made a multi-million U.S. dollar strategic investment in Taboola, an online content discovery platform, according to a company announcement.

On last trading day Express Scripts Holding Company (NASDAQ:ESRX) advanced 0.07% to close at $87.43. Its volatility for the week is 1.30% while volatility for the month is 1.91%. ESRX’s sales growth for past 5 years was 32.50% and its EPS growth for past 5 years was 11.20%. Express Scripts Holding Company (NASDAQ:ESRX) monthly performance is 2.20%. Reportedly on 13 May, the medical expenses for prescription medicines in the U. S are on the rise. In 2014, the medication cost of more than a half-million patients in the U. S. exceeded $50,000. It was a sixty three percent jump from the previous year. The costs went up as, doctors prescribed costlier and more of specialty drugs for treating diseases like hepatitis C and cancer. The report was issued by, Express Scripts Holding Company (NASDAQ:ESRX), the largest pharmacy benefit manager in the U. S. and was called “Super Spending: Trends in High-Cost Medication Use.” In a statement, Express Scripts Holding Company (NASDAQ:ESRX)’s head of clinical, research and new solutions, Glen Stettin, said “These patients are overwhelmingly taking specialty medications, and have multiple (health problems), prescriptions and prescribers.”

Leave a Reply

Your email address will not be published. Required fields are marked *

*